GKB Ophthalmics re-appoints K.G. Gupta, Cedric Lobo at 44th AGM
GKB Ophthalmics held its 44th AGM on August 25, 2026, in Goa. Shareholders approved FY26 standalone and consolidated financial statements. K.G. Gupta and Cedric Lobo were re-appointed to leadership roles. Management cited global geopolitical tensions and supply chain disruptions as key challenges. The company had 2,602 shareholders as on the record date.

*this image is generated using AI for illustrative purposes only.
GKB Ophthalmics held its 44th Annual General Meeting on August 25, 2026, at its registered office in Mapusa, Goa. The gathering focused on governance continuity and the approval of financial results for FY26.
The meeting commenced at 11:00 am and concluded at 11:25 am. Mr. K.G. Gupta, Chairman & Managing Director, chaired the session. The requisite quorum was present, allowing the proceedings to move forward without delay.
Governance Approvals
Shareholders approved several key resolutions during the meeting. These included the adoption of both standalone and consolidated financial statements for the fiscal year ending March 31, 2026.
The board secured approval for the re-appointment of senior leadership. Mr. Vikram Gupta, who retires by rotation, was re-appointed as a director. Additionally, shareholders passed special resolutions to re-appoint Mr. Cedric Lobo as Executive Director and Mr. K.G. Gupta as Chairman and Managing Director.
Operational Context
In his address, the Chairman highlighted significant global economic uncertainty affecting the manufacturing sector. He cited geopolitical tensions, changing trade policies, volatile raw material prices, and supply chain disruptions as key challenges for FY26.
Despite these headwinds, management emphasized a focus on improving operational performance and strengthening market position. The company aims to create lasting value for stakeholders amidst a complex macroeconomic environment.
Meeting Details
The company provided remote e-voting facilities from August 22 to August 24, 2026. Shareholders who did not vote remotely could cast their votes via poll at the meeting. As on the record date of August 18, 2026, the company had 2,602 shareholders.
Statutory auditors MSKA & Associates LLP, secretarial auditor Ms. Girija Nagvekar, and internal auditors RRK & Co attended the meeting. Mr. Shivaram Bhat served as the scrutinizer for the voting process.
Historical Stock Returns for GKB Ophthalmics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -3.08% | -3.08% | -3.08% | -3.08% | -3.08% |
How does GKB Ophthalmics plan to mitigate the impact of volatile raw material prices and supply chain disruptions on its FY27 margins?
What specific operational strategies has management outlined to strengthen market position amidst the cited geopolitical tensions and changing trade policies?
Are there any new product launches or R&D initiatives announced for the upcoming fiscal year to drive growth despite global economic uncertainty?


































